Basic Information
| LncRNA/CircRNA Name | lncRNA-ATB |
| Synonyms | LOC109207222 |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | hepatocellular carcinoma |
| ICD-0-3 | C22.0 |
| Methods | qPCR etc. |
| Sample | serum |
| Expression Pattern | up-regulated |
| Function Description | Eight lncRNAs showed significantly different expression levels (up- or downregulated) between the 2 groups. ATB, EBIC, hDREH, PVT1, SRHC, RERT, and uc002mbe.2 were significantly upregulated, and CUDR was significantly downregulated. |
| Pubmed ID | 27495068 |
| Year | 2016 |
| Title | The long noncoding RNAs PVT1 and uc002mbe.2 in sera provide a new supplementary method for hepatocellular carcinoma diagnosis. |
External Links
| Links for lncRNA-ATB | GenBank HGNC NONCODE |
| Links for hepatocellular carcinoma | OMIM COSMIC |